Annual Current Liabilities
$1.15 B
+$56.27 M+5.15%
01 December 2023
Summary:
Sinovac Biotech annual total current liabilities is currently $1.15 billion, with the most recent change of +$56.27 million (+5.15%) on 01 December 2023. During the last 3 years, it has risen by +$468.29 million (+68.91%). SVA annual current liabilities is now -52.43% below its all-time high of $2.41 billion, reached on 31 December 2021.SVA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$978.45 M
-$169.45 M-14.76%
01 June 2024
Summary:
Sinovac Biotech quarterly total current liabilities is currently $978.45 million, with the most recent change of -$169.45 million (-14.76%) on 01 June 2024. Over the past year, it has dropped by -$169.45 million (-14.76%). SVA quarterly current liabilities is now -70.42% below its all-time high of $3.31 billion, reached on 30 June 2021.SVA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SVA Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -14.8% |
| 3 y3 years | +68.9% | -70.4% |
| 5 y5 years | +1872.2% | +1217.5% |
SVA Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -52.4% | +68.9% | -70.4% | +73.2% |
| 5 y | 5 years | -52.4% | +1872.2% | -70.4% | +1217.5% |
| alltime | all time | -52.4% | >+9999.0% | -70.4% | >+9999.0% |
Sinovac Biotech Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $978.45 M(-14.8%) |
| Dec 2023 | $1.15 B(+5.2%) | $1.15 B(-3.5%) |
| June 2023 | - | $1.19 B(+9.0%) |
| Dec 2022 | $1.09 B(-54.8%) | $1.09 B(+93.3%) |
| June 2022 | - | $564.86 M(-76.6%) |
| Dec 2021 | $2.41 B(+255.0%) | $2.41 B(-27.1%) |
| June 2021 | - | $3.31 B(+386.7%) |
| Dec 2020 | $679.61 M(+679.4%) | $679.61 M(+250.6%) |
| Sept 2020 | - | $193.86 M(+70.8%) |
| June 2020 | - | $113.52 M(+39.6%) |
| Mar 2020 | - | $81.29 M(-6.8%) |
| Dec 2019 | $87.20 M(+49.8%) | $87.20 M(+17.4%) |
| Sept 2019 | - | $74.27 M(+6.4%) |
| June 2019 | - | $69.82 M(+23.5%) |
| Mar 2019 | - | $56.55 M(-2.8%) |
| Dec 2018 | $58.20 M(-37.1%) | $58.20 M(-30.5%) |
| June 2018 | - | $83.80 M(-9.4%) |
| Dec 2017 | $92.54 M(+39.7%) | $92.54 M(+18.9%) |
| June 2017 | - | $77.86 M(+17.5%) |
| Dec 2016 | $66.26 M(+14.0%) | $66.26 M(+0.4%) |
| Sept 2016 | - | $65.98 M(+30.4%) |
| June 2016 | - | $50.61 M(-12.9%) |
| Mar 2016 | - | $58.13 M(-0.0%) |
| Dec 2015 | $58.14 M(-27.2%) | $58.14 M(+14.2%) |
| Sept 2015 | - | $50.90 M(-15.6%) |
| June 2015 | - | $60.35 M(+3.3%) |
| Mar 2015 | - | $58.44 M(-26.8%) |
| Dec 2014 | $79.83 M(+62.4%) | $79.83 M(+11.3%) |
| Sept 2014 | - | $71.72 M(+11.0%) |
| June 2014 | - | $64.60 M(+1.8%) |
| Mar 2014 | - | $63.48 M(+29.1%) |
| Dec 2013 | $49.16 M(+63.0%) | $49.16 M(-2.4%) |
| Sept 2013 | - | $50.38 M(+50.5%) |
| June 2013 | - | $33.48 M(-0.1%) |
| Mar 2013 | - | $33.50 M(+11.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $30.16 M(-23.7%) | $30.16 M(-26.0%) |
| Sept 2012 | - | $40.75 M(+8.5%) |
| June 2012 | - | $37.55 M(+6.4%) |
| Mar 2012 | - | $35.30 M(-10.7%) |
| Dec 2011 | $39.53 M(-13.6%) | $39.53 M(+11.0%) |
| Sept 2011 | - | $35.62 M(+6.1%) |
| June 2011 | - | $33.58 M(-21.9%) |
| Mar 2011 | - | $43.01 M(-6.0%) |
| Dec 2010 | $45.76 M(-10.3%) | $45.76 M(+63.1%) |
| Sept 2010 | - | $28.06 M(+11.8%) |
| June 2010 | - | $25.10 M(-38.8%) |
| Mar 2010 | - | $41.00 M(-19.6%) |
| Dec 2009 | $51.01 M(+139.7%) | $51.01 M(+23.9%) |
| Sept 2009 | - | $41.18 M(+11.3%) |
| June 2009 | - | $36.99 M(+93.5%) |
| Mar 2009 | - | $19.11 M(-10.2%) |
| Dec 2008 | $21.28 M(+4.1%) | $21.28 M(+23.4%) |
| Sept 2008 | - | $17.24 M(-23.1%) |
| June 2008 | - | $22.43 M(+18.8%) |
| Mar 2008 | - | $18.89 M(-7.6%) |
| Dec 2007 | $20.44 M(+72.3%) | $20.44 M(+1.5%) |
| Sept 2007 | - | $20.14 M(+51.3%) |
| June 2007 | - | $13.31 M(+12.2%) |
| Dec 2006 | $11.86 M(+34.2%) | $11.86 M(+29.4%) |
| June 2006 | - | $9.17 M(+3.7%) |
| Dec 2005 | $8.84 M(+32.9%) | $8.84 M(+37.1%) |
| June 2005 | - | $6.45 M(-3.1%) |
| Dec 2004 | $6.66 M(+95.4%) | $6.66 M(+3.7%) |
| Sept 2004 | - | $6.42 M(+18.5%) |
| June 2004 | - | $5.42 M(+59.1%) |
| Dec 2003 | $3.41 M(+2390.2%) | $3.41 M |
| Apr 2002 | $136.80 K(-82.3%) | - |
| Apr 2001 | $773.60 K(+715.2%) | - |
| Apr 2000 | $94.90 K(+2008.9%) | - |
| Apr 1999 | $4500.00 | - |
FAQ
- What is Sinovac Biotech annual total current liabilities?
- What is the all time high annual current liabilities for Sinovac Biotech?
- What is Sinovac Biotech quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Sinovac Biotech?
- What is Sinovac Biotech quarterly current liabilities year-on-year change?
What is Sinovac Biotech annual total current liabilities?
The current annual current liabilities of SVA is $1.15 B
What is the all time high annual current liabilities for Sinovac Biotech?
Sinovac Biotech all-time high annual total current liabilities is $2.41 B
What is Sinovac Biotech quarterly total current liabilities?
The current quarterly current liabilities of SVA is $978.45 M
What is the all time high quarterly current liabilities for Sinovac Biotech?
Sinovac Biotech all-time high quarterly total current liabilities is $3.31 B
What is Sinovac Biotech quarterly current liabilities year-on-year change?
Over the past year, SVA quarterly total current liabilities has changed by -$169.45 M (-14.76%)